Mr. Whitlock joined as Chief Investment Officer on August 3, 2026. Mr. Whitlock leads the Company's investment activities, with responsibility for sourcing, structuring, and executing senior housing investments, cultivating strategic partnerships, and helping guide the continued growth of Chiron's senior housing platform.
Mr. Whitlock brings more than 30 years of senior housing investment and capital markets experience spanning acquisitions, development, investment sales, and debt capital markets. Over the course of his career, he has been involved in more than $20 billion of senior housing transactions, ranging from individual assets to large multi-asset portfolios. His appointment further strengthens Chiron’s senior leadership team as the Company continues to build the capabilities necessary to invest with discipline across a broad range of senior housing opportunities.
Mr. Whitlock joins Chiron from Berkshire Residential Investments, where he served as Managing Director and Chief Investment Officer of Senior Housing Investments. In that role, he was responsible for sourcing senior housing acquisitions and joint venture partnerships, managing the firm’s senior housing investment activities, and creating new debt and equity investment products. He also served on Berkshire’s Investment Committee. Prior to joining Berkshire in 2019, Mr. Whitlock spent more than a decade at CBRE, where he served as Vice Chairman and co-led the firm’s Senior Housing Platform. Earlier in his career, he held senior positions at MMA and Glaser Financial and served as Senior Vice President and Director of Acquisitions at Brookdale Living Communities.
What is Matthew Fitzsimmons Whitlock's net worth?
The estimated net worth of Matthew Fitzsimmons Whitlock is at least $74.22 thousand as of August 17th, 2026. Mr. Whitlock owns 2,000 shares of Global Medical REIT stock worth more than $74,220 as of August 24th. This net worth evaluation does not reflect any other assets that Mr. Whitlock may own. Learn More about Matthew Fitzsimmons Whitlock's net worth.
How do I contact Matthew Fitzsimmons Whitlock?
Has Matthew Fitzsimmons Whitlock been buying or selling shares of Global Medical REIT?
Over the course of the past ninety days, Matthew Fitzsimmons Whitlock has bought $36,795.00 in Global Medical REIT stock. Most recently, on Monday, August 17th, Matthew Fitzsimmons Whitlock bought 500 shares of Global Medical REIT stock. The stock was acquired at an average cost of $36.38 per share, with a total value of $18,190.00. Following the completion of the transaction, the executive now directly owns 2,000 shares of the company's stock, valued at $72,760. Learn More on Matthew Fitzsimmons Whitlock's trading history.
Who are Global Medical REIT's active insiders?
Are insiders buying or selling shares of Global Medical REIT?
In the last year, Global Medical REIT insiders bought shares 16 times. They purchased a total of 92,769 shares worth more than $3,288,892.90. The most recent insider tranaction occured on August, 17th when CIO Matthew Fitzsimmons Whitlock bought 500 shares worth more than $18,190.00. Insiders at Global Medical REIT own 8.9% of the company.
Learn More about insider trades at Global Medical REIT. Information on this page was last updated on 8/17/2026.
